Ambipar Emergency Response
AMBIQ
$0.51
$0.1128.30%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 601.50M | 611.31M | 560.31M | 541.84M | 519.42M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 601.50M | 611.31M | 560.31M | 541.84M | 519.42M |
| Cost of Revenue | 511.57M | 502.89M | 454.49M | 436.87M | 419.19M |
| Gross Profit | 89.93M | 108.42M | 105.82M | 104.97M | 100.23M |
| SG&A Expenses | 6.02M | 5.84M | 6.49M | 6.44M | 5.71M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -6.85M | -288.10K | -1.90M | -1.73M | 21.16M |
| Total Operating Expenses | 510.75M | 508.44M | 459.08M | 441.58M | 446.06M |
| Operating Income | 90.75M | 102.87M | 101.23M | 100.26M | 73.36M |
| Income Before Tax | 25.57M | 37.11M | 46.23M | 42.85M | 22.75M |
| Income Tax Expenses | 12.46M | 13.07M | 14.64M | 18.86M | 18.47M |
| Earnings from Continuing Operations | 13.11 | 24.04 | 31.60 | 23.99 | 4.27 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -15.00M | -15.05M | -17.30M | -16.32M | -15.91M |
| Net Income | -1.89M | 9.00M | 14.30M | 7.67M | -11.64M |
| EBIT | 90.75M | 102.87M | 101.23M | 100.26M | 73.36M |
| EBITDA | 121.24M | 131.54M | 125.53M | 124.84M | 97.84M |
| EPS Basic | -0.03 | 0.16 | 0.26 | 0.14 | 0.02 |
| Normalized Basic EPS | 0.02 | 0.15 | 0.21 | 0.19 | 0.11 |
| EPS Diluted | -0.09 | 0.11 | 0.20 | 0.10 | -0.01 |
| Normalized Diluted EPS | -0.01 | 0.12 | 0.18 | 0.16 | 0.08 |
| Average Basic Shares Outstanding | 221.72M | 221.72M | 221.72M | 221.72M | 359.38M |
| Average Diluted Shares Outstanding | 254.08M | 254.08M | 254.08M | 259.47M | 380.95M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -494.43% | 94.26% | 18.47% | 67.59% | -96.07% |